Australian University Rankings Guide

European Journal of Medicinal Chemistry (ERA Journal)

European Journal of Medicinal Chemistry is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

European Journal of Medicinal Chemistry issns are issn1: 0223-5234 issn2: 1768-3254.

The fields covered by European Journal of Medicinal Chemistry as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Organic Chemistry Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- Antiviral Chemistry and Chemotherapy
- Biological and Pharmaceutical Bulletin
- Bioorganic Chemistry
- ChemBioChem: a European journal of chemical biology
- Current Cancer Drug Targets
- Evolutionary Applications: evolutionary approaches to environmental biomedical and socio-economic issues
- Journal of Biological Inorganic Chemistry
- Journal of Carbohydrate Chemistry
- Journal of Molecular Biology
- Journal of the American Society for Mass Spectrometry
- Magnetic Resonance in Chemistry
- Molecular Medicine
- Molecules
- Organic Preparations and Procedures International: the new journal for organic synthesis
- Organic and Biomolecular Chemistry


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4